Skip to main content
Clinical Trials/ACTRN12607000576426
ACTRN12607000576426CompletedPhase 4

A randomized controlled trial of the effects of low dose zoledronic acid on bone density in osteopenic postmenopausal women

niversity of Auckland0 sites180 target enrollmentStarted: November 9, 2007Last updated:
Conditions

Trial Snapshot

Phase
Phase 4
Status
Completed
Sponsor
Enrollment
180

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Blinded (masking used)

Eligibility Criteria

Ages
o limit to o limit (—)
Sex
Female

Inclusion Criteria

  • Postmenopausal women
  • Bone density T Score < -1 and > -2.5 at lumbar spine or total hip

Exclusion Criteria

  • kidney, liver, thyroid or parathyroid dysfunction
  • current cancer
  • osteoporosis
  • vitamin D deficiency
  • medications known to influence bone metabolism

Investigators

Sponsor
niversity of Auckland

Similar Trials